HLA-DRB1*08 allele may help to distinguish between type 1 diabetes mellitus and type 2 diabetes mellitus in Mexican children

Pediatric Diabetes

Volumn 8, Issue 1, 2007, Pages 5-10

  Rodríguez Ventura, Ana L ^a   Yamamoto Furusho, Jesus K ^b   Coyote, Ninel ^a   Dorantes, Luis M ^a   Ruiz Morales, Jorge A ^b   Vargas Alarcón, Gilberto ^c   Granados, Julio ^b  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Children; HLA; Mexican; T1DM; T2DM

Indexed keywords

AUTOANTIBODY; GENOMIC DNA; HEMOGLOBIN A1C; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR11 ANTIGEN; HLA DR15 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR7 ANTIGEN; METFORMIN; HLA-DRB1 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DIABETIC DIET; DIABETIC KETOACIDOSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC MARKER; HISPANIC; HLA TYPING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEXICO; NON INSULIN DEPENDENT DIABETES MELLITUS; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; CHILD; GENETICS;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; HLA-DR ANTIGENS; HUMANS; MALE; MEXICO;

EID: 33847767687     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2006.00221.x     Document Type: Article

References (60)

1. Nesmith DJ. Type 2 diabetes mellitus in children and adolescents. Pediatr Rev 2001: 22: 147-152.
2. Cara J. Type 2 diabetes mellitus in children. Presented at the Annual Meeting of the American Academy of Pediatrics, Chicago, Illinois, 28 October 2000.
3. Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Pediatr Endocrinol Metab 2000: 13: 1395-1402.
4. Copeland KC, Chalmers LJ, Brown RD. Type 2 diabetes in children: oxymoron or medical metamorphosis? Pediatr Ann 2005: 34: 686-697.
5. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001: 414: 782-787.
6. Arslanian S. Type 2 diabetes mellitus in children: Pathophysiology and risk factors. J Pediatr Endocrinol Metab 2000: 13 (Suppl. 6): 1385-1394.
7. American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics 2000: 105: 671-680.
8. Rosenbloom AL, Joe JR, Young RS, Winter WE. The emerging epidemic of type 2 diabetes mellitus in youth. Diabetes Care 1999: 22: 345-354.
9. Silverstein JH, Rosenbloom AL. Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab 2000: 13: 1403-1409.
10. Hathout EH, Thomas W, El -Shahawy M, Nabab F, Mace JW. Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics 2001: 107: E102.
11. Umpaichitra V, Banerji MA, Castells S. Autoantibodies in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002: 15: 525-530.
12. Atkinson MA, Maclaren NK. What causes diabetes? Sci Am 1990: 7: 42-49.
13. Gorodezky C, Olivares A, Debazo H, Rodríguez L, Altamirano N, Robles C. MHC-dependent molecular mechanisms of susceptibility and protection in type 1 diabetes in Mexicans. Gac Med Mex 1995: 131: 395-403.
14. Yamamoto Furusho JK. El papel del complejo mayor de histocompatibilidad en los procesos infecciosos. Rev Invest Clin 2000: 52: 461-466.
15. Altobelli E, Blasetti A, Petrocelli R et al. HLA DR/DQ alleles and risk of type 1 diabetes in childhood: A population-based case-control study. Clin Exp Med 2005: 5: 72-79.
16. Emery LM, Babu S, Begawan TL et al. Newboorn HLA-DR, DQ genotype screening: Age- and ethnicity-specific type 1 diabetes risk estimates. Pediatr Diabetes 2005: 6: 136-144.
17. Bertera S, Alexander A, Giannoukakis N, Robbins PD, Trucco M. Immunology of type 1 diabetes. Endocrinol Metab Clin 1999: 28: 842-864.
18. Sperling MA. Aspects of the etiology, prediction and prevention of insulin-dependent diabetes mellitus in childhood. Pediatr Clin North Am 1997: 44: 269-283.
19. Ohtsu S, Takubo N, Kazahari N et al. Slowly progressing form of type 1 diabetes mellitus in children: Genetic analysis compared with other forms of diabetes mellitus in Japanese children. Pediatr Diabetes 2005: 6: 221-229.
20. Kukreja A, Maclaren NK. Autoimmunity and diabetes. J Clin Endocrinol Metab 1999: 84: 4371-4378.
21. Tuomilheto-Wolf E, Tuomilheto J, Hitman G et al. Genetic susceptibility to non insulin dependent diabetes mellitus and glucose intolerance are located in HLA region. BMJ 1993: 307: 155-159.
22. Obayashi H, Hasegawa G, Fukui M et al. Tumour necrosis factor microsatelite polymorphism influences the development of insulin dependency in adult-onset diabetes patients with the DRB1*1502-DQB1*0601 allele and antiglutamic acid decarboxylase antibodies. J Clin Endocrinol Metab 2000: 85: 3348-3351.
23. Haiyan L, Eero L, Peter A et al. Possible human leukocyte antigen mediated genetic interaction between type 1 and type 2 diabetes. J Clin Endocrinol Metab 2001: 86: 574-582.
24. Rich SS, Panter SS, Goetz FC, Hedlund B, Barbosa J. Shared genetic susceptibility of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus: Contributions of HLA and haptoglobin. Diabetologia 1991: 34: 350-355.
25. Li H, Isomaa B, Taskinen MR, Groop L, Tuomi T. Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care 2000: 23: 589-594.
26. Kelly MA, Chan JC, Heward J, Mijovic CH. HLA typing and immunological characterization of young-onset diabetes mellitus in a Hong Kong Chinese population. Diabet Med 2001: 18: 22-28.
27. Pandey JP, Zamani M, Cassiman JJ. Epistatic effects of genes encoding tumor necrosis factor-alpha, immunoglobulin allotypes and HLA antigens on susceptibility to non insulin dependent (type 2) diabetes mellitus. Immunogenetics 1999: 49: 860-864.
28. Motala AA, Busson M, Al-Harbi EM et al. Susceptible and protective human leukocyte antigen class II alleles and haplotypes in Bahraini type 2 (non-insulin-dependent) diabetes mellitus patients. Clin Diagn Lab Immunol 2005: 12: 213-217.
29. Perez-Luque E, Alaez C, Malacara JM et al. Protective effect of DRB1 locus against type 2 diabetes mellitus in Mexican Mestizos. Hum Immunol 2003: 64: 110-118.
30. Muir A, Schatz DA, Maclaren NK. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus. Endocrinol Metab Clin North Am 1992: 21: 199-219.
31. Forsblom CM, Sane T, Groop PH. Risk factors for mortality in type II (non-insulin-dependent) diabetes of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia 1998: 41: 1253-1262.
32. Cerna M, Novota P, Kolostova K, Cejkova P. HLA in Czech adult patients with autoimmune diabetes mellitus: Comparison with Czech children with type 1 diabetes and patients with type 2 diabetes. Eur J Immunogenet 2003: 30: 401-407.
33. Banerji MA, Chaiken RL, Huey H et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 1994: 43: 741-745.
34. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997: 20: 1183-1198.
35. García-Ramos G, Zapata-Zuñiga M, Yamamoto-Furusho JK et al. HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis. Eur J Neurol 2003: 10: 707-710.
36. Bekker-Méndez C, Yamamoto-Furusho JK, Vargas-Alarcón G, Ize-Ludlow D, Alcocer-Varela J, Granados J. Haplotype distribution of class II MHC genes in Mexican patients with systemic lupus erythematosus. Scand J Rheumatol 1998: 27: 373-376.
37. Hedley AA, Ogden CL, Johnson CL et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004: 291: 2847-2850.
38. Grubin CE, Daniels T, Toivola B. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994: 37: 344-350.
39. M iller S, D ykes D, P olesky H. A salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
40. Charron D. Genetic diversity of HLA functional and medical implication. Proceedings of the 12th International Histocompatibility Workshop and Conference 1997. Paris, France: EDK, Medical and Scientific International Publisher, 1997.
41. Kauffman FR. Type 2 diabetes in children and youth. Endocrinol Metab Clin North Am 2005: 34: 659-676.
42. Morales A, Wasserfall C, Brusko T et al. Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care 2004: 27: 2010-2014.
43. Makimattila S, Ylitalo K, Schlenzka A. Family histories of type II diabetes and hypertension predict intima-media thickness in patients with type I diabetes. Diabetologia 2002: 45: 711-718.
44. Punnose J, Argawal MM, Mugamer IT. Childhood and adolescent diabetes mellitus in Arabs residing in the United Arab Emirates. Diabetes Res Clin Pract 2002: 55: 29-33.
45. Neufeld N, Raffel LJ, Landon C, Chen YD, Vadheim C. Early presentation of type 2 diabetes in Mexican-American youth. Diabetes Care 1998: 21: 80-86.
46. Hathout EH, Thomas W, El-Shahawy M, Nahab F, Mace JW. Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics 2001: 107: 1-4.
47. Klingensmith GJ, Coombs LP, Arslanian S et al. Autoantibody positivity in subjects screened for participation in a treatment trial for T2D in youth. Diabetes 2006: 55 (Suppl. 1): A67.
48. Reinehr T, Schober E, Wiegand S, Thon A, Holl R. Beta-cell autoantibodies in children with type 2 diabetes mellitus: Subgroup or misclassification? Arch Dis Child 2006: 91: 473-477.
49. Mathis D, Vence L, Benoist C. Beta-cell death during progression to diabetes. Nature 2001: 414: 792-798.
50. Palmer JP, Hampe CS, Chiu H, Goel A, Brooks-Worrell BM. Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age? Diabetes 2005: 54 (Suppl. 2): S62-S67.
51. Vargas-Alarcón G, Hernández-Pacheco G, Gamboa R et al. Polymorphism and distribution of HLA-DR2 alleles in Mexican populations. Hum Immunol 2001: 62: 286-290.
52. Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcón G et al. Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis. Hum Immunol 2003: 64: 119-123.
53. Schoenberg NE, Drew EM. Situating stress: Lessons from lay discourses on diabetes. Med Anthropol Q 2005: 19: 171-193.
54. Umpierrez GE, Woo W, Hagopian WA et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care 1999: 22: 1517-1523.
55. Tan KC, Mackay IR, Zimmet PZ, Hawkins BR, Lam KS. Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus. Diabetes Care 2000: 23: 335-338.
56. Groop L, Miettinen A, Groop PH, Meri S, Koskimies S, Botazzo G. Organ-specific autoimmunity and HLA-DR antigens as markers for B-cell destruction in patients with type II diabetes. Diabetes 1988: 37: 99-103.
57. Aviles-Santa L, Maclaren N, Raskin P. Immune-mediated disease and secondary failure to oral therapy in type 2 diabetes mellitus. J Diabetes Complications 2004: 18: 10-17.
58. Quiroz-Mercado H, Suarez-Licona A, Fromow-Guerra J, Lopez-Carasa G, Granados J. Human lymphocyte antigen DR7 protects against proliferative retinopathy with type 2 diabetes mellitus. Arch Med Res 2002: 33: 123-127.
59. Perez-Luque E, Malacara JM, Olivo-Diaz A. Contribution of HLA class II genes to end stage renal disease in mexican patients with type 2 diabetes mellitus. Hum Immunol 2000: 61: 1031-1038.
60. American Diabetes Association. Economic costs of diabetes in the U.S. Diabetes Care 2003: 26: 917-932.